Roseville, United States
Conception Nurseries, founded in 2018 and headquartered in the United States, is innovating within the Agriculture industry by integrating tissue culture technology into cannabis production. This strategic approach addresses a significant challenge in cannabis cultivation: ensuring plant health and vitality on an industrial scale.
The company’s core value proposition lies in its ability to deliver clean, genetically superior cannabis clones through tissue culture micropropagation. This technology allows Conception to produce disease-free, vigorous plantlets at a cost that undercuts producers' in-house alternatives, resonating with large-scale growers aiming for efficiency and product consistency.
Most recently, the company secured a $50.00K investment in a Venture Round on 14 March 2024. This funding marks a critical step in scaling its operations and further developing its technological capabilities. Conception's innovation and cost-effective solutions position it as a compelling opportunity for investors seeking to capitalize on the expanding cannabis sector.
